The expression of SFRP1 is low in many models of prostate cancer cells, has been proposed this due a methylation-independent mechanism and even it has been proposed SFRP1 as a possible biomarker in the diagnosis of PCa [22–24]. The gene discussed is SFRP1; the disease is posterior cortical atrophy.